No Data
In terms of performance, Youzhiyou Biological (02496.HK) reported an annual loss narrowed to 97.599 million yuan and will not distribute dividends.
Youzhiyou Biological – B (02496.HK) announced its annual results for the year ended last December, with a loss narrowed to 97.599 million yuan (RMB), compared to a loss of 0.192 billion yuan in the same period last year; with a loss per share of 0.5 yuan. During the period, revenue was 0.108 billion yuan. No dividend was declared.
YZYBIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024
YZYBIO-B (02496): The Board of Directors and Supervisory Board re-election.
YZYBIO-B (02496) announced that the nomination process for the candidates of the company directors for the second Board of Directors has been completed...
YZYBIO-B (02496.HK) expects its annual loss to decrease by at least 35%.
On March 24, Gelonghui reported that YZYBIO-B (02496.HK) announced that the group expects the consolidated loss for the fiscal year ending December 31, 2024, to decrease by at least 35% compared to the consolidated loss of RMB 191.7 million for the fiscal year ending December 31, 2023. The Board of Directors believes that the reduction in consolidated loss is primarily due to (i) the Trade under the licensing and cooperation agreement signed with Chengdu Tianqing Pharmaceutical Holdings Co., Ltd. on October 7, 2024; and (ii) incurred listing expenses of approximately RMB 24.6 million in 2023 (2024.
YZYBIO-B: INSIDE INFORMATION -PROFIT ALERT - EXPECTED REDUCTION IN LOSS
YZYBIO-B (02496.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui reported on March 18 that YZYBIO-B (02496.HK) announced that the Board of Directors has scheduled a board meeting on March 28, 2025 (Friday) to consider and approve the annual results and its release for the year ending December 31, 2024, as well as to address other matters.
